胃癌腹膜转移的防治
Prevention and Treatment of Peritoneal Metastases from Gastric Cancer.
作者信息
Sugarbaker Paul H
机构信息
Washington (D.C.) Cancer Institute at Washington Hospital Center, Washington, DC 20007, USA.
出版信息
J Clin Med. 2021 Apr 28;10(9):1899. doi: 10.3390/jcm10091899.
Abstract
Common knowledge would suggest that regional treatments for peritoneal metastases from gastric cancer would not be successful [...].
摘要
常识表明，针对胃癌腹膜转移的局部治疗不会成功[...]。
相似文献
1
Prevention and Treatment of Peritoneal Metastases from Gastric Cancer.胃癌腹膜转移的防治
J Clin Med. 2021 Apr 28;10(9):1899. doi: 10.3390/jcm10091899.
2
Intraperitoneal paclitaxel: pharmacology, clinical results and future prospects.腹腔内注射紫杉醇：药理学、临床结果及未来前景。
J Gastrointest Oncol. 2021 Apr;12(Suppl 1):S231-S239. doi: 10.21037/jgo-2020-03.
3
[Study on association between the expression of galectin- 3 and the peritoneal metastasis in gastric cancer].[半乳糖凝集素-3表达与胃癌腹膜转移相关性的研究]
Zhonghua Wei Chang Wai Ke Za Zhi. 2005 Mar;8(2):151-4.
4
Pathological complete response after intraperitoneal paclitaxel and systemic combined chemotherapy in a patient with peritoneal metastases from gastric cancer: a case report.一名胃癌腹膜转移患者接受腹腔内紫杉醇与全身联合化疗后的病理完全缓解：病例报告
Surg Case Rep. 2020 Mar 30;6(1):63. doi: 10.1186/s40792-020-00818-9.
5
Peritoneal Metastases from Gastrointestinal Cancer.胃肠道癌的腹膜转移。
Curr Oncol Rep. 2018 Jun 8;20(8):62. doi: 10.1007/s11912-018-0703-0.
6
Successful treatment of peritoneal recurrence after gastric cancer surgery with intravenous and intraperitoneal paclitaxel combined with S-1 chemotherapy: a case report.静脉和腹腔注射紫杉醇联合S-1化疗成功治疗胃癌术后腹膜复发：一例报告
Surg Case Rep. 2020 May 1;6(1):88. doi: 10.1186/s40792-020-00849-2.
7
Conversion therapy of gastric cancer with massive malignant ascites and ovarian metastases by systemic and intraperitoneal chemotherapy.采用全身及腹腔内化疗对伴有大量恶性腹水和卵巢转移的胃癌进行转化治疗。
Mol Clin Oncol. 2016 Dec;5(6):740-744. doi: 10.3892/mco.2016.1058. Epub 2016 Oct 21.
8
Proactive Management for Gastric, Colorectal and Appendiceal Malignancies: Preventing Peritoneal Metastases with Hyperthermic Intraperitoneal Chemotherapy (HIPEC).胃癌、结直肠癌和阑尾恶性肿瘤的积极管理：通过腹腔热灌注化疗（HIPEC）预防腹膜转移
Indian J Surg Oncol. 2016 Jun;7(2):215-24. doi: 10.1007/s13193-016-0497-1. Epub 2016 Jan 26.
9
Usefulness of diagnostic laparoscopy with 5-aminolevulinic acid (ALA)-mediated photodynamic diagnosis for the detection of peritoneal micrometastasis in advanced gastric cancer after chemotherapy.诊断性腹腔镜检查联合5-氨基乙酰丙酸（ALA）介导的光动力诊断在检测晚期胃癌化疗后腹膜微转移中的应用价值
Surg Today. 2016 Dec;46(12):1427-1434. doi: 10.1007/s00595-016-1328-2. Epub 2016 Mar 23.
10
[Surgical treatment of peritoneal metastases of gastric cancer].[胃癌腹膜转移的外科治疗]
Chirurg. 2018 Sep;89(9):669-677. doi: 10.1007/s00104-018-0625-2.
引用本文的文献
1
Visualizing the landscape of appendiceal tumor research after 2010: A bibliometric study.2010年后阑尾肿瘤研究全景可视化：一项文献计量学研究
World J Gastrointest Surg. 2024 Jun 27;16(6):1894-1909. doi: 10.4240/wjgs.v16.i6.1894.
2
Gene Expression Profile-Guided Personalized Intraperitoneal Chemotherapy for Gastric Cancer Peritoneal Carcinomatosis.基因表达谱指导的胃癌腹膜转移个体化腹腔内化疗
World J Oncol. 2024 Apr;15(2):298-308. doi: 10.14740/wjon1578. Epub 2024 Mar 21.
3
Efficacy of Traditional Chinese Medicine Combined with Chemotherapy in the Treatment of Gastric Cancer: A Meta-analysis.中药联合化疗治疗胃癌的疗效：Meta 分析。
Comput Math Methods Med. 2022 Aug 4;2022:8497084. doi: 10.1155/2022/8497084. eCollection 2022.
4
Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Combined with Surgery: A 12-Year Meta-Analysis of this Promising Treatment Strategy for Advanced Gastric Cancer at Different Stages.腹腔内热灌注化疗（HIPEC）联合手术：不同阶段晚期胃癌这种有前途的治疗策略的 12 年荟萃分析。
Ann Surg Oncol. 2022 May;29(5):3170-3186. doi: 10.1245/s10434-021-11316-z. Epub 2022 Feb 17.
5
Imaging of Gastric Carcinomatosis.胃癌腹膜转移的影像学表现
J Clin Med. 2021 Nov 14;10(22):5294. doi: 10.3390/jcm10225294.
6
Molecular Cytology by One-Step Nucleic Acid Amplification (OSNA) Assay of Peritoneal Washings during D2 Gastrectomy in Advanced Gastric Cancer Patients: Preliminary Results.进展期胃癌患者D2胃切除术中通过腹膜灌洗一步核酸扩增（OSNA）检测进行分子细胞学分析：初步结果
J Clin Med. 2021 Nov 10;10(22):5230. doi: 10.3390/jcm10225230.
本文引用的文献
1
Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer With Peritoneal Metastases (CYTO-CHIP study): A Propensity Score Analysis.细胞减灭术联合或不联合腹腔热灌注化疗治疗胃癌腹膜转移（CYTO-CHIP 研究）：倾向评分分析。
J Clin Oncol. 2019 Aug 10;37(23):2028-2040. doi: 10.1200/JCO.18.01688. Epub 2019 May 14.
2
Phase III Trial Comparing Intraperitoneal and Intravenous Paclitaxel Plus S-1 Versus Cisplatin Plus S-1 in Patients With Gastric Cancer With Peritoneal Metastasis: PHOENIX-GC Trial.紫杉醇腹腔内和静脉给药联合 S-1 对比顺铂联合 S-1 治疗胃癌伴腹膜转移患者的 III 期临床试验：PHOENIX-GC 试验。
J Clin Oncol. 2018 Jul 1;36(19):1922-1929. doi: 10.1200/JCO.2018.77.8613. Epub 2018 May 10.
3
Current status and future prospects of clinical trials on CRS + HIPEC for gastric cancer peritoneal metastases.胃癌腹膜转移患者实施细胞减灭术联合腹腔热灌注化疗的临床研究现状与展望。
Int J Hyperthermia. 2017 Aug;33(5):562-570. doi: 10.1080/02656736.2017.1283065.
4
CRS-HIPEC Prolongs Survival but is Not Curative for Patients with Peritoneal Carcinomatosis of Gastric Cancer.CRS-HIPEC可延长胃癌腹膜转移患者的生存期，但无法治愈该疾病。
Ann Surg Oncol. 2016 Nov;23(12):3972-3977. doi: 10.1245/s10434-016-5306-0. Epub 2016 Jun 16.
5
Peritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival and risk factors.胃源性腹膜癌：基于人群的发病率、生存率和危险因素研究。
Int J Cancer. 2014 Feb 1;134(3):622-8. doi: 10.1002/ijc.28373. Epub 2013 Aug 5.
6
Effects of neoadjuvant intraperitoneal/systemic chemotherapy (bidirectional chemotherapy) for the treatment of patients with peritoneal metastasis from gastric cancer.新辅助腹腔/全身化疗（双向化疗）对胃癌腹膜转移患者的治疗效果。
Int J Surg Oncol. 2012;2012:148420. doi: 10.1155/2012/148420. Epub 2012 Jul 31.
Zotero 插件